Rani Therapeutics Files 8-K: Other Events & Exhibits
Ticker: RANI · Form: 8-K · Filed: Jul 16, 2025 · CIK: 1856725
| Field | Detail |
|---|---|
| Company | Rani Therapeutics Holdings, Inc. (RANI) |
| Form Type | 8-K |
| Filed Date | Jul 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, filing, exhibits
Related Tickers: RANI
TL;DR
Rani Therapeutics (RANI) filed an 8-K on July 14th for other events and exhibits - check for details.
AI Summary
On July 14, 2025, Rani Therapeutics Holdings, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant occurrences. No specific financial figures or new events were detailed in the provided excerpt.
Why It Matters
This 8-K filing signals that Rani Therapeutics Holdings, Inc. is making important disclosures to the SEC, which could impact investors' understanding of the company's current situation and future prospects.
Risk Assessment
Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain specific material events or financial data that would indicate a high-risk situation.
Key Players & Entities
- Rani Therapeutics Holdings, Inc. (company) — Registrant
- July 14, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-40672 (identifier) — Commission File Number
- 2051 Ringwood Avenue (address) — Principal executive offices
- San Jose, California (location) — Principal executive offices
- 95131 (zip_code) — Principal executive offices
- (408) 457-3700 (phone_number) — Registrant's Telephone Number
FAQ
What specific "Other Events" are being reported by Rani Therapeutics Holdings, Inc. in this 8-K filing?
The provided excerpt does not detail the specific "Other Events" being reported; it only indicates that this item is included in the filing.
What "Financial Statements and Exhibits" are being filed by Rani Therapeutics Holdings, Inc.?
The excerpt states that "Financial Statements and Exhibits" are part of the filing, but does not list the specific documents included.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 14, 2025.
What is the Commission File Number for Rani Therapeutics Holdings, Inc.?
The Commission File Number for Rani Therapeutics Holdings, Inc. is 001-40672.
Where are Rani Therapeutics Holdings, Inc.'s principal executive offices located?
Rani Therapeutics Holdings, Inc.'s principal executive offices are located at 2051 Ringwood Avenue, San Jose, California, 95131.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 16, 2025 regarding Rani Therapeutics Holdings, Inc. (RANI).